Thursday, May 29, 2014

Gene Technology Regains Some of Its Luster

Alnylam Pharmaceuticals and a few other drug firms are rekindling interest in once-hot gene technology, which seeks to disable molecules called RNA from translating genetic code into disease-causing proteins.



from WSJ.com: US Business http://ift.tt/1juJKND

via IFTTT

No comments:

Post a Comment